Prof. Silvano Adami, Italy
Silvano Adami, MD, is Head of the Rheumatologic Rehabilitation Unit of the University of Verona, where he also serves as Associate Professor in Rheumatology. His clinical activities center on metabolic bone diseases, rheumatology, and endocrinology and he has published over 300 scientific papers that discuss bone diseases and their treatment. Dr. Adami sits on the editorial boards of several specialized international journals, including Osteoporosis International, European Journal of Endocrinological Investigation, and Journal of Bone Densitometry. He is Associated Editor of Aging, Clinical, and Experimental Research and is a member of the Scientific Board of the International Osteoporosis Foundation (IOF). A native of Verona, Dr. Adami graduated cum laude in medicine at the University of Padua and later specialized in internal medicine and endocrinology. Among his postgraduate education, he was Research Fellow at the Department of Internal Medicine of Middlesex Hospital Medical School of London.
Prof. John P. Bilezikian, USA
John P. Bilezikian, Professor for Medicine and Pharmacology, serves as Chief of the Division of Endocrinology at the College of Physicians and Surgeons at Columbia-Presbyterian Medical Center, where is Director of the Metabolic Bone Diseases program. A member of numerous scientific societies, Dr. Bilezikian is a former President of the American Society for Bone and Mineral Research, and is currently President of the International Society for Clinical Densitometry. He is Editor-in-Chief of the Journal of Clinical Endocrinology and Metabolism. Dr. Bilezikian leads an active laboratory program and has authored over 320 publications.
Prof. Peter Burckhardt, Switzerland
Treasurer of IOF as of March 1, 2004
Formerly Chief of Medical Service A, at the University Hospital of Lausanne, Professor Burckhardt has published numerous articles on metabolic bone diseases, calcium metabolism, osteoporosis and clinical nutrition. He is on the editorial board of Osteoporosis International. Professor Burckhardt is past president of the Swiss Society of Internal Medicine and the Swiss Osteoporosis Association and is member of several Swiss, American and international scientific societies.
Prof. Juliet Compston, UK
Juliet Compston is Reader in Metabolic Bone Diseases at the University of Cambridge School of Clinical Medicine. She is immediate past President of the Bone and Tooth Society of Great Britain and of the International Society of Bone Morphometry. She is a member of the Council of Management of the National Osteoporosis Society and a member of Council of the European Calcified Tissues Society. Dr Compston was co-author of the 1998 Report on Osteoporosis in the European Community and is Project Leader of the Call to Osteoporosis Action, a project funded by the European Union to ensure implementation of the recommendations of the EC Report. She also represents the IOF on the Bone and Joint Health Strategies Project. Dr Compston combines clinical and research work and has a particular interest in the mechanisms by which bone active drugs affect the skeleton. She also has an interest in clinical guidelines and has chaired the working groups for the Royal College of Physicians/Bone and Tooth Society Update on the Prevention and Treatment of Osteoporosis and for the Bone and Tooth Society/National Osteoporosis Society and Royal College of Physicians Guidelines on the Management of Glucocorticoid-induced Osteoporosis.
Prof. Steven Cummings, USA
Steven Cummings is Professor of Medicine and Epidemiology at the University of California, San Francisco and Director of the UCSF Coordinating Center. He has published widely in scientific journals and is co-editor of the book "Osteoporosis: An Evidence-based Guide to Prevention and Management" from the American College of Physicians. He has been principal investigator of the Study of Osteoporotic Fractures, Men's Osteoporosis Study (Mr. OS), Fracture Intervention Trial (FIT) and other multicenter studies of osteoporosis. He is also investigator and consultant for the Beijing Osteoporosis and Osteoarthritis and Latin American Vertebral Osteoporosis Studies. Professor Cummings serves on the IOF Board of Scientific Advisors, the National Osteoporosis Foundation Board of Trustees, and is the Chair of the Hong Kong Jockey Club Osteoporosis Center's International Advisory Board. He was on the American Society for Bone and Mineral Research Council from 1997 to 1999 and co-organized the 4th International Osteoporosis Symposium (NOF) in Honolulu.
Prof. Bess Dawson-Hughes, USA
Bess Dawson-Hughes, M.D., is a Professor of Medicine at Tufts University and Director of the Bone Metabolism Laboratory at the Jean Mayer United States Department of Agriculture Human Nutrition Research Center on Aging at Tufts University. She is trained in endocrinology and directs the Metabolic Bone Diseases Clinic at the Tufts-New England Medical Center.
Prof. Dawson-Hughes has been on the Board of Trustees of the National Osteoporosis Foundation since 1995. In 2002, she began a 3-year term as the President of the NOF. She is currently on the Council of the International Bone and Mineral Society and the Advisory Council of the National Institute of Arthritis, Musculoskeletal, and Skin Diseases. She has served in the past on the councils of the American Society for Bone and Mineral Research and the American Society of Clinical Nutrition. From 1994-2002, she was an Associate Editor of the Journal of Bone and Mineral Research. Prof. Dawson-Hughes has published over 280 peer-reviewed journal articles, book chapters, abstracts, and reviews. Her current research is directed at examining ways in which calcium, vitamin D, protein and other nutrients influence age-related loss of bone mass and risk of fragility fractures.
Prof. Pierre D. Delmas, France
President of IOF
Pierre D. Delmas is Professor of Medicine and Rheumatology at the Université Claude Bernard in Lyon. As Director of the INSERM Research Unit on Pathophysiology of Osteoporosis at the Edouard Herriot Hospital of Lyon, he manages basic and clinical research programs in the field of metabolic bone diseases with special focus on osteoporosis. He has authored over 400 articles in international scientific publications and is the Associate Editor of the journals Osteoporosis International and Bone. As President of the IOF, Professor Delmas is actively involved in the development of international educational programs on osteoporosis.
Prof. Harry K. Genant, USA
Harry K. Genant, MD, is Professor Emeritus of the University of California San Francisco, and Chairman of the Board of Directors of Synarc, Inc.
Prof. Olof Johnell, Sweden
Prof. John Kanis, UK
As the Director of a WHO Collaborating Centre for Metabolic Bone Diseases (Sheffield) and advisor for various multinational nongovernmental organisations and government departments, Dr. Kanis has a multidisciplinary background in bone disease (including basic and clinical research, health technology assessment, epidemiology and health economics). He is the author of over 500 publications and an award-winning osteoporosis text book. Prof. Kanis is an editor of Bone and is on the editorial boards of several peer-reviewed journals.
Marcel Lechanteur, Belgium
Marcel Lechanteur has been a senior executive of Eli Lilly since 1991, including serving as global marketing director for osteoporosis products with a worldwide portfolio valued at $1 billion sales. He is concurrently managing director, Switzerland, based in Geneva. He received graduate degrees in business administration from Cornell University (US) and University of Louvain (Belgium) and a law degree from University of Liege (Belgium). He is fluent in English, French and Dutch.
Prof. Rubem Lederman, Brazil
In 1999 Professor Lederman, a rheumatologist, was nominated President of the Brazilian Society of Osteoporosis. He was President of the Brazilian Society of Rheumatology from 1982 to 1984 and of the Brazilian Academy of Rheumatology from 1994 to 1996. He was also President of the International Ibero American Committee from 1994 to 1998. Professor Lederman works at the Department of Rheumatology from the Hospital dos Servidores do Estado do Rio de Janeiero and has published widely in international medical journals.
Prof. Uri Liberman, Israel
Professor Liberman is currently Head of the Division of Endocrinology and Metabolism at the Sackler Facutly of Medicine, Tel Aviv University, in Petah Tikvah, Israel. He earned his medical degree at Hebrew University and Hadassah Medical School in Jerusalem and his Ph.D. at the University of California in San Francisco. An active researcher who has authored more than 130 articles in peer-reviewed journals as well as several book chapters, Professor Liberman is a member of different international research societies and the President of the Israeli Bone and Mineral Society and the Israeli Osteoporosis Association.
He is also a member of the WHO Task Force on Osteoporosis and is on the scientific committees of numerous national and international meetings and organizations.
Dr. Ghassan Maalouf, Lebanon
Dr. Maalouf is an orthopaedic surgeon who has published many articles on osteoporosis and participated in numerous research studies at a local, regional and international level. As a co-founder of the Lebanese Osteoporosis Prevention Society and the Pan Arab Osteoporosis Society, Dr. Maalouf enthusiastically represents IOF and the work of the Foundation in the Middle East. He has been the driving force behind numerous public education and media activities as well as international and regional medical conferences in the field of osteoporosis.
Dr. Paul D. Miller, USA
Founding President of International Society for Clinical Densitometry, Paul D. Miller has been active in many professional organizations and is a noted clinical researcher. Dr. Miller is editor of the widely published Journal of Clinical Densitometry.
Prof. Helmut W. Minne, Germany
Chairman, Committee of National Societies
Professor Helmut Minne is an endocrinologist educated at the universities of Frankfurt and Göttingen. His extensive research activities include the development of animal models for skeletal-metabolism based diseases, diagnostic procedures, therapeutic clinical trials, and the assessment of quality of life in osteoporosis patients. Professor Minne founded the German osteoporosis society Kuratorim Knochengesundheit, and was one of the founders of the German Academy of Osteological and Rheumatological Sciences (as well as a founder of the IFSSD, which merged with EFFO to become IOF). He is editor of the German Mobiles Leben and of Osteoporosis Action.
Prof. Hirotoshi Morii, Japan
Professor Morii graduated from the University of Tokyo in 1958. He has been Professor of Medicine at Osaka City University since 1984 and was named Professor Emeritus in 1999. He was the President of the Second International Conference on Osteoporosis that was held in Osaka in 1997 and was elected President of the Japan Osteoporosis Foundation (JOF) in 1999. Professor Morii is responsible for the international affairs in JOF which has played a major role in increasing awareness of the disease and improving patient care in Japan.
Prof. Socrates Papapoulos, the Netherlands
A graduate of the University of Athens in Greece, Professor Papapoulos is currently Professor of Medicine and Director of Bone and Mineral Research at the Dept. of Endocrinology and Metabolic Diseases, University of Leiden Medical Center. He has authored more than two hundred publications on bone and mineral metabolism and has served as editor or on the editorial board of several scientific journals. Professor Papapoulos was President of the Dutch Society for Calcium and Bone Metabolism from 1993 to 1996.
Prof. Jean-Yves Reginster, Belgium
Executive Secretary of IOF
Professor Reginster is currently Professor of Epidemiology and Public Health, Head of the Bone and Cartilage Resarch Unit and Director of the WHO collaborating Center for Public Health Aspects of Osteo-articular Disorders at the University of Liege, Belgium. He is an active researcher who has authored more than 500 publications, mainly dedicated to pathophysiology of osteo-arthritis, epidemiology of osteoporosis and arthritis, health economics, clinical management of osteoporosis and osteo-arthritis. Among his other professional activities, Professor Reginster is Executive Secretary of the Belgium Bone Club and on the Board of the Osteo-Arthritis Research Society International (OARSI).
Prof. Gregorio Riera-Espinoza, Venezuela
Gregorio Riera-Espinoza is Director of UNILIME-UC, Clinical Research Center for Osteoporosis and Mineral Metabolism and Associate Professor of Medicine at the Universidad de Carabobo, Valencia, Venezuela. Dr. Riera obtained his medical degree and specialization in internal medicine at the University of Carabobo. He consequently specialized in clinical nephrology at the University of Chicago, Pritzer School of Medicine, Chicago, USA and in mineral metabolism at the Fundación Jiménez Díaz, Universidad Autónoma de Madrid in Spain. Dr. Riera is actively involved in Latin American research projects such as Peak Bone Mass, Bone Turnover, Male Osteoporosis, Prevalence, Vertebral Fractures (LAVOS), and different pharmaceutical multicenter clinical trials. He is the Director of training programs such as the Postgraduate Course (2 year program) in Mineral Metabolism at the University of Carabobo. He is a member of the Board of the Venezuelan Society of Menopause and Osteoporosis and was President and organizer of the III IOF Latin American Congress on Osteoporosis and the IV Congreso Venezolano de Menopausia y Osteoporosis, Isla de Margarita, October 2002.
Prof. René Rizzoli, Switzerland
Chairman of the Committee of Scientific Advisors
Professor Rizzoli is a specialist in endocrinology and metabolic bone diseases and teaches at the departments of internal medicine, geriatrics, pathophysiology and experimental endocrinology at the University of Geneva. He has published widely, is an editorial board member and reviewer for various scientific journals and associate editor of European Journal of Endocrinology. Professor Rizzoli is a member of numerous international bone and mineral research societies as well as on the scientific board of the European Calcified Tissue and the Swiss Bone and Mineral Societies.
Prof. Ego Seeman, Australia
A clinical professor in the Dept. of Medicine and Endocrinology at the Austin Hospital in Melbourne, Professor Seeman has a long background in osteoporosis research beginning with his work with Larry Riggs at the Mayo Clinic in Rochester, MN, USA in the early 80's. He was a panel member on the WHO committee for the development of the definition of osteoporosis. Professor Seeman is Editor of "Advances in Osteoporosis" and on the editorial board of several international journals. His research interests include skeletal growth and development, osteoporosis in women and men and costicosteroid related osteoporosis. Professor Seeman is the also the editor of IOF's new publication "Progress in Osteoporosis".
Ethel S. Siris, USA
Ethel S. Siris, MD, is the Madeline C. Stabile Professor of Clinical Medicine in the Department of Medicine, College of Physicians and Surgeons of Columbia University, and the Director of the Toni Stabile Osteoporosis Center of the Columbia-Presbyterian Medical Center, both in New York, New York. She is a graduate of Radcliffe College, Harvard University, and received her medical degree from the College of Physicians and Surgeons of Columbia University. An endocrinologist, she has worked as a clinician, clinical investigator and medical educator in the area of metabolic bone diseases, including osteoporosis, Paget's disease of bone, and the skeletal complications of cancer. In particular, she has worked extensively with the class of bisphosphonate compounds in these disorders as well as with selective estrogen receptor modulators (SERMS) in osteoporosis.
Dr. Siris is a member of the Board of Trustees of the National Osteoporosis Foundation, where she chairs the Science and Research Committee, and is Vice Chair of the Paget Foundation for Paget's Disease of Bone and Related Disorders; she has previously served as a member of the Council of the American Society for Bone and Mineral Research and the Endocrinologic and Metabolic Drugs Advisory Committee of the US Food and Drug Administration. She is co-editor of the book, The Bone and Mineral Manual, and is a member of the editorial boards of the Journal of Bone and Mineral Research, Osteoporosis International, and the Journal of Clinical Densitometry.
Dr. Siris serves as the Medical Director of the National Osteoporosis Risk Assessment, NORA, a public health initiative and longitudinal study of osteoporosis that includes over 200,000 postmenopausal women in the US.
Yannis Tsouderos, France
Dr. Tsouderos was trained at the University of Medicine of Paris as MD specialist in Physiology, Rheumatology, Rehabilitation and Reeducation and Internal Medicine. He carried out clinical activities at the "Hôpitaux de Paris" for 24 years before joining the Institut de Recherches Internationales SERVIER (I.R.I.S). He was involved in clinical research and development of several new drugs. Dr. Tsouderos is currently in charge of the Direction of the Therapeutic Research and Development (I.R.I.S).
Prof. José Zanchetta, Argentina
Prof. Zanchetta is Chief Executive Officer of the Metabolic Research Institute in Buenos Aires, Argentina. He is Full Professor of Osteology at USAL University in Buenos Aires where he directs the Osteology and Mineral Metabolism Department. With more than 20 years experience in the field of metabolic diseases and as a principal investigator in clinical trials on drug development, Prof. Zanchetta has authored extensively in different local and international scientific publications. In 1992 Prof. Zanchetta initiated and founded the Argentine Osteoporosis Society (SAO) and became the society's first president.